{"id": "https://openalex.org/I1283582996", "ror": "https://ror.org/02f9zrr09", "display_name": "Novartis (Switzerland)", "country_code": "CH", "type": "company", "type_id": "https://openalex.org/institution-types/company", "lineage": ["https://openalex.org/I1283582996"], "homepage_url": "https://www.novartis.com/", "image_url": "https://commons.wikimedia.org/w/index.php?title=Special:Redirect/file/Novartis-Logo.svg", "image_thumbnail_url": "https://commons.wikimedia.org/w/index.php?title=Special:Redirect/file/Novartis-Logo.svg&width=300", "display_name_acronyms": [], "display_name_alternatives": [], "repositories": [{"id": "https://openalex.org/S4306400709", "display_name": "The Novartis Repository (Novartis)", "host_organization": "https://openalex.org/I1283582996", "host_organization_name": "Novartis (Switzerland)", "host_organization_lineage": ["https://openalex.org/I1283582996"]}], "works_count": 33316, "cited_by_count": 5296918, "summary_stats": {"2yr_mean_citedness": 7.968260730642241, "h_index": 720, "i10_index": 54180}, "ids": {"openalex": "https://openalex.org/I1283582996", "ror": "https://ror.org/02f9zrr09", "wikipedia": "https://en.wikipedia.org/wiki/Novartis", "wikidata": "https://www.wikidata.org/wiki/Q507154"}, "geo": {"city": "Basel", "geonames_city_id": "2661604", "region": null, "country_code": "CH", "country": "Switzerland", "latitude": 47.55839157104492, "longitude": 7.573269844055176}, "international": {}, "associated_institutions": [{"id": "https://openalex.org/I4210086790", "ror": "https://ror.org/0013shd50", "display_name": "Novartis (Germany)", "country_code": "DE", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210090302", "ror": "https://ror.org/00dhvr506", "display_name": "Novartis (India)", "country_code": "IN", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210091341", "ror": "https://ror.org/00fxgea47", "display_name": "Novartis (China)", "country_code": "CN", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210092929", "ror": "https://ror.org/00geypp27", "display_name": "Novartis (France)", "country_code": "FR", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210095812", "ror": "https://ror.org/00jkyke88", "display_name": "Novartis (South Korea)", "country_code": "KR", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210104729", "ror": "https://ror.org/01a80cj23", "display_name": "Novartis (Netherlands)", "country_code": "NL", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210105804", "ror": "https://ror.org/01k1ftz35", "display_name": "Novartis (Japan)", "country_code": "JP", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210107130", "ror": "https://ror.org/01psm3828", "display_name": "Novartis (Israel)", "country_code": "IL", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210116309", "ror": "https://ror.org/01msnnq69", "display_name": "Novartis (Sweden)", "country_code": "SE", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210117619", "ror": "https://ror.org/028fhxy95", "display_name": "Novartis (United States)", "country_code": "US", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210118192", "ror": "https://ror.org/02hdkm455", "display_name": "Novartis (Slovakia)", "country_code": "SK", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210120247", "ror": "https://ror.org/01w8m1867", "display_name": "Novartis (Australia)", "country_code": "AU", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210122481", "ror": "https://ror.org/027f4r073", "display_name": "Novartis (Denmark)", "country_code": "DK", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210124465", "ror": "https://ror.org/02v66pf20", "display_name": "Novartis (Singapore)", "country_code": "SG", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210125565", "ror": "https://ror.org/02dbytc62", "display_name": "Novartis (Mexico)", "country_code": "MX", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210129647", "ror": "https://ror.org/039s6n838", "display_name": "Novartis (United Kingdom)", "country_code": "GB", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210139938", "ror": "https://ror.org/04rcxhq50", "display_name": "Novartis (Italy)", "country_code": "IT", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210142907", "ror": "https://ror.org/04kqbrq68", "display_name": "Novartis (Hungary)", "country_code": "HU", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210143510", "ror": "https://ror.org/042e6sa59", "display_name": "Novartis (Spain)", "country_code": "ES", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210145533", "ror": "https://ror.org/05he4e720", "display_name": "Novartis (Belgium)", "country_code": "BE", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210151500", "ror": "https://ror.org/04qhpra63", "display_name": "Novartis (Norway)", "country_code": "NO", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210152716", "ror": "https://ror.org/0504mbn59", "display_name": "Novartis (Slovenia)", "country_code": "SI", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210154767", "ror": "https://ror.org/04sgnw557", "display_name": "Novartis (Ireland)", "country_code": "IE", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210155630", "ror": "https://ror.org/04t24x986", "display_name": "Novartis (Austria)", "country_code": "AT", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4210161737", "ror": "https://ror.org/05afs3z13", "display_name": "Novartis (Canada)", "country_code": "CA", "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4388891806", "ror": "https://ror.org/02rse7p59", "display_name": "Sandoz Group AG (Switzerland)", "country_code": null, "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4391012540", "ror": "https://ror.org/02z899n24", "display_name": "Novartis Gene Therapies Switzerland GmbH", "country_code": null, "type": "company", "relationship": "child"}, {"id": "https://openalex.org/I4400600974", "ror": "https://ror.org/053gv2m95", "display_name": "Novartis Institutes for BioMedical Research", "country_code": null, "type": "other", "relationship": "child"}, {"id": "https://openalex.org/I860889466", "ror": "https://ror.org/01bmjkv45", "display_name": "Friedrich Miescher Institute", "country_code": "CH", "type": "facility", "relationship": "related"}], "counts_by_year": [{"year": 2025, "works_count": 703, "oa_works_count": 511, "cited_by_count": 853}, {"year": 2024, "works_count": 982, "oa_works_count": 715, "cited_by_count": 7368}, {"year": 2023, "works_count": 1189, "oa_works_count": 869, "cited_by_count": 16484}, {"year": 2022, "works_count": 1273, "oa_works_count": 821, "cited_by_count": 16604}, {"year": 2021, "works_count": 1203, "oa_works_count": 730, "cited_by_count": 28060}, {"year": 2020, "works_count": 1044, "oa_works_count": 640, "cited_by_count": 31166}, {"year": 2019, "works_count": 1037, "oa_works_count": 620, "cited_by_count": 40976}, {"year": 2018, "works_count": 1018, "oa_works_count": 583, "cited_by_count": 55104}, {"year": 2017, "works_count": 960, "oa_works_count": 533, "cited_by_count": 56732}, {"year": 2016, "works_count": 1146, "oa_works_count": 515, "cited_by_count": 44981}, {"year": 2015, "works_count": 1175, "oa_works_count": 530, "cited_by_count": 61130}, {"year": 2014, "works_count": 1166, "oa_works_count": 536, "cited_by_count": 58156}, {"year": 2013, "works_count": 1102, "oa_works_count": 502, "cited_by_count": 56450}, {"year": 2012, "works_count": 1019, "oa_works_count": 404, "cited_by_count": 60271}, {"year": 2011, "works_count": 904, "oa_works_count": 336, "cited_by_count": 62806}, {"year": 2010, "works_count": 875, "oa_works_count": 314, "cited_by_count": 67853}], "roles": [{"role": "funder", "id": "https://openalex.org/F4320307778", "works_count": 8040}, {"role": "institution", "id": "https://openalex.org/I1283582996", "works_count": 33316}], "topics": [{"id": "https://openalex.org/T10211", "display_name": "Computational Drug Discovery Methods", "count": 974, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/1703", "display_name": "Computational Theory and Mathematics"}, "field": {"id": "https://openalex.org/fields/17", "display_name": "Computer Science"}, "domain": {"id": "https://openalex.org/domains/3", "display_name": "Physical Sciences"}}, {"id": "https://openalex.org/T10911", "display_name": "Chemical Synthesis and Analysis", "count": 920, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/1312", "display_name": "Molecular Biology"}, "field": {"id": "https://openalex.org/fields/13", "display_name": "Biochemistry, Genetics and Molecular Biology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T11016", "display_name": "Monoclonal and Polyclonal Antibodies Research", "count": 909, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2741", "display_name": "Radiology, Nuclear Medicine and Imaging"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10051", "display_name": "Asthma and respiratory diseases", "count": 887, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2737", "display_name": "Physiology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10077", "display_name": "Neuroscience and Neuropharmacology Research", "count": 837, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2804", "display_name": "Cellular and Molecular Neuroscience"}, "field": {"id": "https://openalex.org/fields/28", "display_name": "Neuroscience"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T11178", "display_name": "Receptor Mechanisms and Signaling", "count": 830, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/1312", "display_name": "Molecular Biology"}, "field": {"id": "https://openalex.org/fields/13", "display_name": "Biochemistry, Genetics and Molecular Biology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T11235", "display_name": "Statistical Methods in Clinical Trials", "count": 817, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2613", "display_name": "Statistics and Probability"}, "field": {"id": "https://openalex.org/fields/26", "display_name": "Mathematics"}, "domain": {"id": "https://openalex.org/domains/3", "display_name": "Physical Sciences"}}, {"id": "https://openalex.org/T10804", "display_name": "Health Systems, Economic Evaluations, Quality of Life", "count": 788, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2002", "display_name": "Economics and Econometrics"}, "field": {"id": "https://openalex.org/fields/20", "display_name": "Economics, Econometrics and Finance"}, "domain": {"id": "https://openalex.org/domains/2", "display_name": "Social Sciences"}}, {"id": "https://openalex.org/T10908", "display_name": "Analytical Chemistry and Chromatography", "count": 785, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/1607", "display_name": "Spectroscopy"}, "field": {"id": "https://openalex.org/fields/16", "display_name": "Chemistry"}, "domain": {"id": "https://openalex.org/domains/3", "display_name": "Physical Sciences"}}, {"id": "https://openalex.org/T11215", "display_name": "Chronic Myeloid Leukemia Treatments", "count": 730, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2720", "display_name": "Hematology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T11157", "display_name": "Chronic Lymphocytic Leukemia Research", "count": 674, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2716", "display_name": "Genetics"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10469", "display_name": "Psoriasis: Treatment and Pathogenesis", "count": 555, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2403", "display_name": "Immunology"}, "field": {"id": "https://openalex.org/fields/24", "display_name": "Immunology and Microbiology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T10375", "display_name": "Pharmacogenetics and Drug Metabolism", "count": 519, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/3004", "display_name": "Pharmacology"}, "field": {"id": "https://openalex.org/fields/30", "display_name": "Pharmacology, Toxicology and Pharmaceutics"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T10137", "display_name": "Multiple Sclerosis Research Studies", "count": 511, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2734", "display_name": "Pathology and Forensic Medicine"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10200", "display_name": "Rheumatoid Arthritis Research and Therapies", "count": 491, "score": 0.9998999834060669, "subfield": {"id": "https://openalex.org/subfields/2745", "display_name": "Rheumatology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10837", "display_name": "Dermatology and Skin Diseases", "count": 456, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2708", "display_name": "Dermatology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T11092", "display_name": "Spondyloarthritis Studies and Treatments", "count": 453, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2745", "display_name": "Rheumatology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10952", "display_name": "PI3K/AKT/mTOR signaling in cancer", "count": 433, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/1312", "display_name": "Molecular Biology"}, "field": {"id": "https://openalex.org/fields/13", "display_name": "Biochemistry, Genetics and Molecular Biology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T12547", "display_name": "Pharmaceutical studies and practices", "count": 430, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2735", "display_name": "Pediatrics, Perinatology and Child Health"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T12505", "display_name": "Peptidase Inhibition and Analysis", "count": 428, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2730", "display_name": "Oncology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10143", "display_name": "Chronic Obstructive Pulmonary Disease (COPD) Research", "count": 427, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2740", "display_name": "Pulmonary and Respiratory Medicine"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10170", "display_name": "Retinal Diseases and Treatments", "count": 421, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2731", "display_name": "Ophthalmology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10373", "display_name": "Renal Transplantation Outcomes and Treatments", "count": 419, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2747", "display_name": "Transplantation"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T11616", "display_name": "Autoimmune and Inflammatory Disorders Research", "count": 419, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2720", "display_name": "Hematology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10755", "display_name": "HER2/EGFR in Cancer Research", "count": 418, "score": 1.0, "subfield": {"id": "https://openalex.org/subfields/2730", "display_name": "Oncology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}], "topic_share": [{"id": "https://openalex.org/T12829", "display_name": "Advanced Breast Cancer Therapies", "value": 0.0084624, "subfield": {"id": "https://openalex.org/subfields/2740", "display_name": "Pulmonary and Respiratory Medicine"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T11235", "display_name": "Statistical Methods in Clinical Trials", "value": 0.0083938, "subfield": {"id": "https://openalex.org/subfields/2613", "display_name": "Statistics and Probability"}, "field": {"id": "https://openalex.org/fields/26", "display_name": "Mathematics"}, "domain": {"id": "https://openalex.org/domains/3", "display_name": "Physical Sciences"}}, {"id": "https://openalex.org/T12255", "display_name": "Biosimilars and Bioanalytical Methods", "value": 0.0083879, "subfield": {"id": "https://openalex.org/subfields/2403", "display_name": "Immunology"}, "field": {"id": "https://openalex.org/fields/24", "display_name": "Immunology and Microbiology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T11215", "display_name": "Chronic Myeloid Leukemia Treatments", "value": 0.0077816, "subfield": {"id": "https://openalex.org/subfields/2720", "display_name": "Hematology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T11092", "display_name": "Spondyloarthritis Studies and Treatments", "value": 0.0075391, "subfield": {"id": "https://openalex.org/subfields/2745", "display_name": "Rheumatology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10469", "display_name": "Psoriasis: Treatment and Pathogenesis", "value": 0.0072459, "subfield": {"id": "https://openalex.org/subfields/2403", "display_name": "Immunology"}, "field": {"id": "https://openalex.org/fields/24", "display_name": "Immunology and Microbiology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T11308", "display_name": "Sphingolipid Metabolism and Signaling", "value": 0.0072223, "subfield": {"id": "https://openalex.org/subfields/1312", "display_name": "Molecular Biology"}, "field": {"id": "https://openalex.org/fields/13", "display_name": "Biochemistry, Genetics and Molecular Biology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T13736", "display_name": "Steroid Chemistry and Biochemistry", "value": 0.0058694, "subfield": {"id": "https://openalex.org/subfields/1312", "display_name": "Molecular Biology"}, "field": {"id": "https://openalex.org/fields/13", "display_name": "Biochemistry, Genetics and Molecular Biology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T10952", "display_name": "PI3K/AKT/mTOR signaling in cancer", "value": 0.0056873, "subfield": {"id": "https://openalex.org/subfields/1312", "display_name": "Molecular Biology"}, "field": {"id": "https://openalex.org/fields/13", "display_name": "Biochemistry, Genetics and Molecular Biology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T10137", "display_name": "Multiple Sclerosis Research Studies", "value": 0.0055002, "subfield": {"id": "https://openalex.org/subfields/2734", "display_name": "Pathology and Forensic Medicine"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T11798", "display_name": "Optimal Experimental Design Methods", "value": 0.0053813, "subfield": {"id": "https://openalex.org/subfields/1803", "display_name": "Management Science and Operations Research"}, "field": {"id": "https://openalex.org/fields/18", "display_name": "Decision Sciences"}, "domain": {"id": "https://openalex.org/domains/2", "display_name": "Social Sciences"}}, {"id": "https://openalex.org/T11616", "display_name": "Autoimmune and Inflammatory Disorders Research", "value": 0.0050138, "subfield": {"id": "https://openalex.org/subfields/2720", "display_name": "Hematology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T12281", "display_name": "Animal testing and alternatives", "value": 0.0042296, "subfield": {"id": "https://openalex.org/subfields/3404", "display_name": "Small Animals"}, "field": {"id": "https://openalex.org/fields/34", "display_name": "Veterinary"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T11001", "display_name": "Renin-Angiotensin System Studies", "value": 0.0042146, "subfield": {"id": "https://openalex.org/subfields/2705", "display_name": "Cardiology and Cardiovascular Medicine"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T11628", "display_name": "Myeloproliferative Neoplasms: Diagnosis and Treatment", "value": 0.004138, "subfield": {"id": "https://openalex.org/subfields/2716", "display_name": "Genetics"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T11533", "display_name": "Melanoma and MAPK Pathways", "value": 0.0040268, "subfield": {"id": "https://openalex.org/subfields/1312", "display_name": "Molecular Biology"}, "field": {"id": "https://openalex.org/fields/13", "display_name": "Biochemistry, Genetics and Molecular Biology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T10755", "display_name": "HER2/EGFR in Cancer Research", "value": 0.003949, "subfield": {"id": "https://openalex.org/subfields/2730", "display_name": "Oncology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10211", "display_name": "Computational Drug Discovery Methods", "value": 0.0038768, "subfield": {"id": "https://openalex.org/subfields/1703", "display_name": "Computational Theory and Mathematics"}, "field": {"id": "https://openalex.org/fields/17", "display_name": "Computer Science"}, "domain": {"id": "https://openalex.org/domains/3", "display_name": "Physical Sciences"}}, {"id": "https://openalex.org/T10845", "display_name": "Advanced Causal Inference Techniques", "value": 0.0038623, "subfield": {"id": "https://openalex.org/subfields/2613", "display_name": "Statistics and Probability"}, "field": {"id": "https://openalex.org/fields/26", "display_name": "Mathematics"}, "domain": {"id": "https://openalex.org/domains/3", "display_name": "Physical Sciences"}}, {"id": "https://openalex.org/T11157", "display_name": "Chronic Lymphocytic Leukemia Research", "value": 0.0038562, "subfield": {"id": "https://openalex.org/subfields/2716", "display_name": "Genetics"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10375", "display_name": "Pharmacogenetics and Drug Metabolism", "value": 0.0038273, "subfield": {"id": "https://openalex.org/subfields/3004", "display_name": "Pharmacology"}, "field": {"id": "https://openalex.org/fields/30", "display_name": "Pharmacology, Toxicology and Pharmaceutics"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T11792", "display_name": "Pharmaceutical Economics and Policy", "value": 0.0038075, "subfield": {"id": "https://openalex.org/subfields/2002", "display_name": "Economics and Econometrics"}, "field": {"id": "https://openalex.org/fields/20", "display_name": "Economics, Econometrics and Finance"}, "domain": {"id": "https://openalex.org/domains/2", "display_name": "Social Sciences"}}, {"id": "https://openalex.org/T11124", "display_name": "Protein purification and stability", "value": 0.0037999, "subfield": {"id": "https://openalex.org/subfields/1312", "display_name": "Molecular Biology"}, "field": {"id": "https://openalex.org/fields/13", "display_name": "Biochemistry, Genetics and Molecular Biology"}, "domain": {"id": "https://openalex.org/domains/1", "display_name": "Life Sciences"}}, {"id": "https://openalex.org/T10200", "display_name": "Rheumatoid Arthritis Research and Therapies", "value": 0.0035476, "subfield": {"id": "https://openalex.org/subfields/2745", "display_name": "Rheumatology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}, {"id": "https://openalex.org/T10051", "display_name": "Asthma and respiratory diseases", "value": 0.0034301, "subfield": {"id": "https://openalex.org/subfields/2737", "display_name": "Physiology"}, "field": {"id": "https://openalex.org/fields/27", "display_name": "Medicine"}, "domain": {"id": "https://openalex.org/domains/4", "display_name": "Health Sciences"}}], "is_super_system": false, "works_api_url": "https://api.openalex.org/works?filter=institutions.id:I1283582996", "updated_date": "2025-12-23T23:15:37.779995", "created_date": "2016-06-24T00:00:00"}